# India Dexamethasone and Betamethasone

> **NCT03668860** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 48 (actual)

## Conditions studied

- Preterm Birth
- Antenatal Corticosteroids

## Interventions

- **DRUG:** Dexamethasone 4 mg/ml
- **DRUG:** Betamethasone 4 mg/ml
- **DRUG:** Celestone Soluspan 6Mg/Ml Suspension for Injection
- **DRUG:** Dexamethasone Oral Tablet
- **DRUG:** Betamethasone Oral Tablet

## Key facts

- **NCT ID:** NCT03668860
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-20
- **Primary completion:** 2019-02-28
- **Final completion:** 2019-12-31
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-07-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03668860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03668860, "India Dexamethasone and Betamethasone". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03668860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*